6126
M. Dabiri et al. / Tetrahedron Letters 46 (2005) 6123–6126
4. Moore, J. A.; Sutherland, G. J.; Sowerby, R.; Kelly, E. G.;
Palermo, S.; Webster, W. J. Org. Chem. 1969, 887–892.
5. Su, W.; Yang, B. Aust. J. Chem. 2002, 55, 695–697.
6. Shi, D.; Rong, L.; Wang, J.; Zhuang, Q.; Wang, X.; Hu,
H. Tetrahedron Lett. 2003, 44, 3199–3201.
7. (a) Sadanandam, Y. S.; Reddy, K. R. M.; Rao, A. B. Eur.
J. Org. Chem. 1987, 22, 169–173; (b) Reo, V. B.; Ratnam,
C. V. Indian J. Chem. 1979, 18B, 409–412.
8. For reviews, see: (a) Pandey, G.; Singh, R. P.; Gary, A.;
Singh, V. K. Tetrahedron Lett. 2005, 46, 2137–2140; (b)
Werner, B.; Domling, A. Molecules 2003, 8, 53–66; (c)
Domling, A.; Ugi, I. Angew. Chem., Int. Ed. 2000, 39,
3169–3210; (d) Kappe, C. O. Acc. Chem. Res. 2000, 33,
879–888; (e) Terret, N. K.; Gardner, M.; Gordon, D. W.;
Kobylecki, R. J.; Steele, J. Tetrahedron 1995, 51, 8135–
8173.
Tables 2 and 3). After completion of the reaction as indi-
cated by TLC (eluent: 1/3 ethyl acetate–n-hexane), the
solid catalyst was separated by filtration. Water
(10 mL) was added and the precipitated product was
filtered and recrystallized from EtOH.15
Preparation of 2,3-disubstituted 2,3-dihydroquinazoline-
4(1H)-ones in H2O. Alum (0.2 g) was added to a mixture
of isatoicanhydride (1 mmol), primary amine (1.1 mmol)
and aldehyde (1 mmol) in water. The mixture was heated
at reflux for 1 h (see Table 2). After completion of the
reaction, the solid residue was separated, washed with
water (10 mL) and recrystallized from ethanol.
9. Strecker, A. Liebigs Ann. Chem. 1850, 75, 27–45.
10. (a) Domling, A. Curr. Opin. Chem. Biol. 2002, 6, 306–313;
(b) Weber, L. Drug Discovery Today 2002, 7, 143–147.
11. Dabiri, M.; Salehi, P.; Mohammadi, Ali A.; Baghban-
zadeh, M. Synth. Commun. 2005, 35, 287–295.
12. (a) Tewari, N.; Dwivedi, N.; Tripathi, R. P. Tetrahedron
Lett. 2004, 45, 9011–9014; (b) Zolfigol, M. A.; Safaiee, M.
Synlett 2004, 827–828.
Acknowledgement
Financial support from the Research Council of Shahid
Beheshti University is gratefully acknowledged.
References and notes
13. Dabiri, M.; Salehi, P.; Mohammadi, Ali A.; Baghban-
zadeh, M.; Khozehgiry, Gh. J. Chem. Res. (S) 2004, 570–
572.
1. (a) Hour, M.; Huang, L.; Kuo, S.; Xia, Y.; Bastow, K.;
Nakanishi, Y.; Hamel, E.; Lee, K. J. Med. Chem. 2000, 43,
4479–4487; (b) Misra, V. S.; Saxena, V. K.; Srivastava, R.
Indian J. Pharm. Sci. 1983, 45, 207–211; (c) Kacker, I. K.;
Zaheer, S. H. J. Indian Chem. Soc. 1951, 28, 344–348; (d)
Gupta, R. C.; Nath, R.; Shanker, K.; Bhargava, K. P.;
Kishore, K. J. Indian Chem. Soc. 1979, 56, 219–220; (e)
Parmar, S. S.; Kumar, R.; Arora, R. C. Indian J. Med.
Res. 1969, 57, 245–248.
2. (a) Abdel-Jalil, R. J.; Volter, W.; Saeed, M. Tetrahedron
Lett. 2004, 45, 3475–3476; (b) Lopez, S. E.; Rosales, M.
E.; Urdaneta, N.; Godoy, M. V.; Charris, J. E. J. Chem.
Res. (S) 2000, 258–259; (c) Rao, V. B.; Hanumanthu, P.;
Rantnam, C. V. Indian J. Chem. 1979, 18B, 493–496.
3. (a) Johne, S. Pharmazie 1981, 36, 583–596; (b) Mannsch-
reck, A.; Koller, H.; Stuhler, G.; Davies, M. A.; Traber,
J. E. J. Med. Chem. 1994, 19, 381–383; (c) Sharma, S. D.;
Kaur, V. Synthesis 1989, 677–680; (d) Cizmarik, J.; Trupe,
J. Pharmazie 1987, 42, 139–140; (e) Kung, P. P.; Casper,
M. D.; Cook, K. L.; Willson-Lin-gardo, L. J. Med. Chem.
1999, 42, 4705–4713; (f) Corbett, J. W.; Ko, S. S.;
Rodgers, J. D.; Gearhart, L. A.; Magnus, N. A.; Bachh-
eler, L. T.; Diamond, S.; Jeffey, S.; Trainor, G. L.;
Anderson, P. S.; Erickson-Vitanen, K. J. Med. Chem.
2000, 43, 2019–2030; (g) Liu, J. F.; Lee, J.; Dalton, A. M.;
Bi, G.; Yu, L.; Baldino, C. M.; McElory, E.; Brown, M.
Tetrahedron Lett. 2005, 46, 1241–1244.
14. Yale, L. H.; Kalkstein, M. J. Med. Chem. 1967, 10, 334–
336.
À1
15. C17H17N3O3 4n: IR (KBr) (mmax, c m ): 3420, 1680 (C@O);
1H NMR (CDCl3, 500 MHz) dH: 0.94 (3H, t, J = 7.3 Hz),
1.64 (2H, m), 2.77 (1H, ddd, J = 14.1, 8.59, 5.8 Hz), 4.05
(1H, ddd, J = 13.9, 8.7, 6.6 Hz), 5.82 (1H, s, CH), 6.5–8.2
(8H, m, arom); 13C NMR (CDCl3) dC: 12.5, 22.3, 48.1,
71.9, 116.0, 117.4, 120.9, 125.3 (2C), 128.3 (2C), 129.5,
134.9, 145.4, 148.3, 149.2, 164.1 (C@O); MS (m/z, %): 311
(M+, 64), 174 (47.6), 119 (45.2), 105 (44.3), 77 (51.6).
À1
C16H16O2N2 4o: IR (KBr) (mmax, c m ): 3440, 1680 (C@O);
1H NMR (DMSO-d6 500 MHz) dH: 1.0 (3H, t, CH3,
J = 7.08 Hz), 2.83 (1H, dq, J = 13.6, 7.02 Hz), 3.71 (dq,
1H, J = 13.6, 7.16 Hz), 5.73 (1H, d, J = 1.9 Hz), 6.6–6.7
(4H, m), 7.11–7.18 (3H, m), 7.20 (1H, d, J = 1.9, NH), 7.62
(1H, dd, J = 7.6, 1.4 Hz), 9.48 (1H, s, OH); 13C NMR
(DMSO-d6) dC: 14.6, 71.6, 115.6, 116.3, 116.7 (2C), 118.5,
128.9, 129.3 (2C), 133.0, 134.4, 148.1, 159.2, 163.3 (C@O);
MS (m/z, %): 268 (M+, 60), 174 (67.1), 105 (53.5),À717 (40.5).
C10H14N2O 7a: mp 88–90 °C; IR (KBr) (mmax, c m ): 3440,
1
3290, 1620 (C@O); H NMR (CDCl3, 500 MHz) dH: 1.24
(3H, t, J = 1.25 Hz), 2.98 (3H, s), 3.45 (2H, q,
J = 7.25 Hz), 6.03 (1H, br d, NH), 6.5–7.3 (4H, m), 7.49
(1H, br d, NH); 13C NMR (CDCl3) dC: 14.9, 29.7, 34.5,
111.1, 114.5, 115.4, 127.0, 132.6, 150.3, 169.8; MS (m/z, %):
178 (M+, 70), 119 (60.4), 104 (69.5), 77 (52.2).